Sinphar Pharmaceutical Co., Ltd. — Investor Relations & Filings
Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司114年第二季合併財務報告 董事會召開日期為114年08月12日 | 2025-08-04 | Chinese | |
| 114年6月背書保證與資金貸與 | 2025-07-10 | Chinese | |
| 114年6月營業收入 | 2025-07-10 | Chinese | |
| 114年06月內部人持股異動(事後) | 2025-07-08 | Chinese | |
| 114年06月董事會成員及持股 | 2025-07-08 | Chinese | |
| 114年年報及股東會資料 — 2025_1734_20250619FE3.pdf | 2025-07-04 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 33457380 | 公告本公司114年第二季合併財務報告 董事會召開日期為114年08月12日 | 2025-08-04 | Chinese | ||
| 33457389 | 114年6月背書保證與資金貸與 | 2025-07-10 | Chinese | ||
| 33457384 | 114年6月營業收入 | 2025-07-10 | Chinese | ||
| 33457398 | 114年06月內部人持股異動(事後) | 2025-07-08 | Chinese | ||
| 33457393 | 114年06月董事會成員及持股 | 2025-07-08 | Chinese | ||
| 33462326 | 114年年報及股東會資料 — 2025_1734_20250619FE3.pdf | 2025-07-04 | Chinese | ||
| 33462313 | 114年年報及股東會資料 — 2025_1734_20250619F05.pdf | 2025-07-04 | Chinese | ||
| 33462292 | 114年年報及股東會資料 — 2025_1734_20250619F17.pdf | 2025-07-04 | Chinese | ||
| 33462284 | 114年年報及股東會資料 — 2024_1734_20250619FE4.pdf | 2025-07-04 | Chinese | ||
| 33462246 | 114年年報及股東會資料 — 2024_1734_20250619F04.pdf | 2025-07-04 | Chinese | ||
| 33462225 | 114年年報及股東會資料 — 2025_1734_20250619FE1.pdf | 2025-07-04 | Chinese | ||
| 33462215 | 114年年報及股東會資料 — 2025_1734_20250619F02.pdf | 2025-07-04 | Chinese | ||
| 33462195 | 114年年報及股東會資料 — 2025_1734_20250619FE2.pdf | 2025-07-04 | Chinese | ||
| 33462180 | 114年年報及股東會資料 — 2025_1734_20250619F13.pdf | 2025-07-04 | Chinese | ||
| 33462168 | 114年年報及股東會資料 — 2025_1734_20250619F01.pdf | 2025-07-04 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sinphar Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51911/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51911 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51911 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51911 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51911}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sinphar Pharmaceutical Co., Ltd. (id: 51911)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.